What: The NIH will host a summit of researchers, scientists and clinicians to discuss the advances and research priorities in the field of Alzheimer's disease-related dementias (ADRDs), in particular updating what progress has been made since the first summit held in May 2013.
Who: The National Institute of Neurological Disorders and Stroke is leading this meeting.
When: March 29-30, at 8 a.m. in the Natcher Auditorium, NIH Campus, 9000 Rockville Pike, Bethesda, MD.
Why: The Alzheimer's disease-related dementias include frontotemporal dementia (FTD), Lewy body dementia, mixed etiology dementia, Parkinson disease, and vascular contributions to cognitive impairment and dementia. Tackling ADRDs is part of the National Alzheimer's Project Act (NAPA), a plan to combat Alzheimer's disease signed into law by President Barack Obama in January 2011. At the first summit, a team of experts developed a plan for addressing the scientific and clinical challenges of understanding ADRDs.
RSVP: Media registrations please RSVP to the firstname.lastname@example.org
The meeting registration site: https:/
A video cast link will be provided during the meeting.
About NINDS: NINDS is the nation's leading funder of research on the brain and nervous system. The mission of NINDS is to seek fundamental knowledge about the brain and nervous system and to use that knowledge to reduce the burden of neurological disease.
About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit http://www.